Juvenile xanthogranuloma
☆ AI Dermatology — Free Service
A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
relevance score : -100.0%
ReferencesJuvenile xanthogranuloma (JXG) cuta ce da ta zama ruwan dare gama gari kuma galibi nau'in non‑Langerhans cell histiocytic disorder a yara. A kusan 75 % na lokuta, waɗannan raunuka suna bayyana a cikin shekarun farko na rayuwa, kuma fiye da 15‑20 % na marasa lafiya suna da su tun haihuwa. Ko da yake ba kasafai a manya ba, JXG yawanci yana faruwa mafi yawa a tsakanin mutane a ƙarshen shekaru ashirin zuwa talatin, kuma mafi yawan marasa lafiya manya suna da rauni ɗaya ne kawai. A asibiti, cutar tana bayyana a matsayin guda ɗaya ko fiye da haka na ƙwayoyin rawaya‑orange‑launin ruwan kasa masu ƙarfi ko dunƙulewa, galibi a fuska, wuya, da kan sama. Raunin baki ba sabon abu ba ne, amma yana iya bayyana a matsayin dunƙule rawaya a gefen harshe ko wani wuri a cikin baki, wanda zai iya haifar da ƙwaryar (ulcers) da zubar da jini. Raunin fata yawanci ba ya haifar da alamar cuta kuma yakan warke da kansa bayan shekaru da dama. Ko da yake ba kasafai ba, shigar ido (ocular involvement) shi ne mafi yawan damuwa fiye da fata, sannan shigar huhu (pulmonary involvement) na biyo baya. Ocular JXG yawanci yana shafar ido ɗaya ne kawai kuma yana faruwa a ƙasa da 0.5 % na marasa lafiya, kodayake kusan kashi 40 % na waɗanda ke da shigar ido suna da raunuka da yawa idan an gano su.
Juvenile xanthogranuloma (JXG) is a relatively common entity and is the most common form of non-Langerhans cell histiocytic disorder of childhood., It is estimated that in 75% of cases, lesions appear during the first year of life, with >15-20% of patients having lesions at birth. JXG is rare in adults, with a peak incidence in the late twenties to thirties. The majority of adult patients have solitary lesions. Typically, the clinical presentation consists of solitary or multiple yellow-orange-brown firm papules or nodules. The most common locations are the face, neck, and upper torso. Oral lesions are rare and often occur as a yellow nodule on the lateral aspects of the tongue. Oral lesions can also arise on the gingival, buccal mucosa, and midline hard palate and may ulcerate and bleed. Cutaneous lesions are usually asymptomatic, and most lesions spontaneously involute over the course of several years. Although occurring rarely, ocular involvement is the most common extracutaneous site involved, followed by the lungs. Ocular JXG is nearly always unilateral and develops in less than 0.5% of patients. Approximately 40% of patients with ocular JXG, however, have multiple cutaneous lesions at the time of diagnosis.
Juvenile xanthogranuloma (JXG) is a relatively common entity and is the most common form of non-Langerhans cell histiocytic disorder of childhood., It is estimated that in 75% of cases, lesions appear during the first year of life, with >15-20% of patients having lesions at birth. JXG is rare in adults, with a peak incidence in the late twenties to thirties. The majority of adult patients have solitary lesions. Typically, the clinical presentation consists of solitary or multiple yellow-orange-brown firm papules or nodules. The most common locations are the face, neck, and upper torso. Oral lesions are rare and often occur as a yellow nodule on the lateral aspects of the tongue. Oral lesions can also arise on the gingival, buccal mucosa, and midline hard palate and may ulcerate and bleed. Cutaneous lesions are usually asymptomatic, and most lesions spontaneously involute over the course of several years. Although occurring rarely, ocular involvement is the most common extracutaneous site involved, followed by the lungs. Ocular JXG is nearly always unilateral and develops in less than 0.5% of patients. Approximately 40% of patients with ocular JXG, however, have multiple cutaneous lesions at the time of diagnosis.
Juvenile xanthogranulomas (JXGs) cuta ce da ba a saba gani ba, waɗanda ke cikin babban nau'in non‑Langerhans cell histiocytoses. Yawanci suna bayyana a matsayin guda ɗaya ko fiye masu launin ja ko rawaya, galibi a kai ko wuya. Yawancin JXGs suna tasowa ko dai a lokacin haihuwa ko a cikin shekarar farko ta rayuwa. Duk da yake ba su da yawa, wani lokaci suna iya shafar wuraren da ba su takaita ga fata ba, kuma idan suka shafi ido, ya kamata a duba su sosai bisa ga adabin da ake da shi. Gabaɗaya, JXGs a kan fata suna warkewa da kansu kuma yawanci ba su bukatar magani.
Juvenile xanthogranulomas (JXGs) are uncommon, benign diseases that are part of a larger category of non-Langerhans cell histiocytoses. They typically show up as one or more red or yellowish lumps, often found on the head or neck. Most JXGs develop either at birth or within the first year of life. While it's unusual, sometimes they can affect areas beyond the skin, with eye involvement being something to watch for according to existing literature. Generally, JXGs on the skin go away on their own and typically don't need treatment.
Juvenile xanthogranulomas (JXGs) are uncommon, benign diseases that are part of a larger category of non-Langerhans cell histiocytoses. They typically show up as one or more red or yellowish lumps, often found on the head or neck. Most JXGs develop either at birth or within the first year of life. While it's unusual, sometimes they can affect areas beyond the skin, with eye involvement being something to watch for according to existing literature. Generally, JXGs on the skin go away on their own and typically don't need treatment.
Raunin ido yana bayyana a kusan 10 % na mutanen da ke da JXG kuma yana iya shafar hangen nesa. Ko da yake raunukan fata suna ɓacewa ba zato ba tsammani, raunin ido da na wuya na bukatar kulawa da magani ba da daɗewa ba.